Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Webinar on Advances in Lung Cancer Surgery, with Dr. David Harpole
Author
Howard (Jack) West, MD

GRACE in partnership with LUNGevity Foundation are thrilled to offer our next webinar on Wednesday, October 24th, at 6:30 PM Eastern/3:30 PM Pacific, with the renowned Dr. David Harpole, Thoracic Surgeon and Professor of Surgery at Duke University Medical Center. Dr. Harpole is a great leader in the field of lung surgery who is also a great collaborator with other specialists in lung cancer who thinks a lot about molecular testing and other advances. He'll join us to speak about advances in lung cancer surgery over the past few years and evolving standards.

The program will include his presentation for about 45 minutes, followed by a question and answer session with our live audience.  Registration is free, and through this link.  

We'll turn the program into a series of podcasts that will be available here, on the LUNGevity website, and through iTunes and YouTube, but we hope you'll join us and participate in the live program on Wednesday, October 24th.

Next Previous link

Previous PostNext Post

Related Content

Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.